Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Coronary Artery Disease Drugs News Monitoring

Get by Email • RSS

Published on May 6, 2025

New Analysis Published in Nature Medicine Demonstrates Advantages of Nationwide Coronary CTA Strategy with Heartflow ...

MOUNTAIN VIEW, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced two-year data from FISH&CHIPS, a real-world, multicenter, retrospective study, conducted by the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on 02:09 GMT

ACE Inhibitors Show Lower Risk of MACE for Older Patients With Type 2 Diabetes

For older patients with type 2 diabetes (T2D), initiating treatment with angiotensin-converting enzyme inhibitors (ACEIs) was associated with a trend toward lower risk of major adverse cardiac events (MACE) compared with angiotensin II receptor blockers ( …

Source: Drug Topics - Neutral
Published on 00:52 GMT

Evolocumab May Shift Plaque Profile Toward Lower Cardiovascular Risk

Evolocumab may help reshape high-risk plaque in the arteries, with the drug reducing microcalcification activity and shifting plaque toward a lower-risk profile over 18 months in patients with extensive noncalcified plaque at baseline in a new study.1 …

Source: Consultant Live - Pending
Published on 12:24 GMT

Heart Attack Vs Cardiac Arrest: What’s The Difference?

Heart attack, cardiac arrest – they’re basically the same thing, right? Nope – while they both involve the heart, they are in fact two very different things, with a variety of different causes, symptoms, and treatments. One simple way to think about the …

Source: IFL Science - Neutral
Published on 11:59 GMT

4 High-Yielding Dogs of the Dow Are Crushing the Major Indices

Investing 400tmax / iStock Unreleased via Getty Images Investors love dividend stocks, especially high-yield ones, because they offer significant income streams and have substantial total return potential. Total return includes interest, capital gains, …

Source: 24/7 Wall St. - Neutral
Published on May 8, 2025

AI-enabled CCTA evaluations reduce use of invasive imaging exams

Another key takeaway from the group’s findings was that FFRCT Analysis helped identify more patients who required percutaneous coronary intervention (PCI). Overall, approximately one extra appropriate PCI patient was detected for every two unnecessary …

Source: Health Imaging - Neutral
Published on 10:20 GMT

Delayed Diagnosis and Outcomes in Acute Aortic Dissection: A 10-Year Single-Center Retrospective Study

Introduction Acute aortic dissection (AAD) is a rare and life-threatening condition that remains challenging to diagnose and treat. The common presentation of AAD includes sudden, severe chest and back pain.1–3 However, AAD’s clinical manifestations vary …

Source: Dove Medical Press - Neutral
Published on 02:55 GMT

Limited Role for ICI Rechallenge in RCC Spurs Interest in More Tailored Later-Line Strategies

Despite the lack of clinical benefit generated by immune checkpoint inhibitor (ICI) rechallenge for most patients with advanced renal cell carcinoma (RCC) who have progressed on prior immunotherapy, ongoing research is seeking to clarify the application of …

Source: OncLive - Pending
Published on 00:57 GMT

Obicetrapib slashes LDL cholesterol by over 30% in high-risk heart patients

In a global trial of over 2,500 patients, obicetrapib dramatically reduced LDL cholesterol levels when added to standard lipid-lowering therapy, offering new hope for those at highest cardiovascular risk. Study: Safety and Efficacy of Obicetrapib in …

Source: Medical News - Neutral
Published on May 8, 2025

Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients With or at Risk of Atherosclerotic Cardiovascular Disease

The fixed-dose combination (FDC) of obicetrapib (NewAmsterdam Pharma) plus ezetimibe (Zetia; Merck and Schering-Plough Pharmaceuticals) significantly reduced low-density lipoprotein cholesterol (LDL-C) in patients with pre-existing or at high risk for …

Source: Pharmacy Times - Neutral
Published on May 8, 2025

The Two-Step Answer to Protecting Your Nerves, Heart, and Brain

Who knew a rash could sound so romantic? Scientists have described it as "dew drops on rose petals"... specifically, the blisters in chickenpox. Unless you got the jab when the vaccine came out in 1995, you likely experienced a feeling of general …

Source: Stansberry Research - Pending
Published on May 8, 2025

LEQVIO Strengthens Position As Leader In Cholesterol-Lowering Therapies Across Seven Major Markets Delveinsight

(MENAFN- PR Newswire) LEQVIO marks a significant advancement in hypercholesterolemia management, particularly for patients not achieving target LDL-C levels despite maximally tolerated statin therapy. As the first FDA-approved siRNA therapy for LDL-C …

Source: MENAFN - Indeterminate
Published on May 8, 2025

Veru Participates in a Virtual Investor KOL Connect Segment

-- Moderated discussion with preeminent obesity expert, Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder, of Veru -- MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 6, 2025

Research: How Cholesterol Drug May Prevent Heart Attacks

Newswise — LOS ANGELES (May 5, 2025) -- A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease—a leading cause of death in the United States. Coronary artery …

Source: Newswise - Neutral
Published on May 8, 2025

Predictive Value of IL-6 and PDGF-AA for 28-Day Mortality Risk in Critical Ill Patients

Introduction The complexity of a patient’s disease and severity of organ dysfunction are associated with mortality in critically ill patients. The clinician’s challenge is to make decisions regarding the daily practice of intensive care. Clinicians must …

Source: Dove Medical Press - Neutral
Published on May 8, 2025

Link Between Depression and Heart Failure in US Veterans Uncovered

Recent research published in JAMA Network Open has shed new light on the complex interplay between mental health and cardiovascular disease, specifically focusing on the veteran population. This cohort study provides compelling evidence that depression …

Source: Bioengineer.org - Pending
Published on May 5, 2025

Sleep Apnea: Types, Causes, Symptoms and Treatments

The American Medical Association reports that about 30 million people in the US live with sleep apnea, but only one-fifth of these cases are clinically diagnosed. That means that many people are living with undiagnosed and untreated sleep apnea. This is …

Source: CNET - Pending
Published on May 8, 2025

Medical Bulletin 08/ May/ 2025

Vitamin D Slashes Colorectal Cancer Risk by 58%: Study Finds A recent study published in the journal Nutrients has revealed that adequate intake of vitamin D may reduce the risk of developing colorectal cancer by up to 58%. This significant finding adds to …

Source: Medical Dialogues - Indeterminate
Published on May 8, 2025

Precision Medicine Transforms Cardiovascular Care

Early detection and targeted treatment of cardiovascular diseases to extend healthy lifespans are becoming increasingly achievable due to advances in precision medicine. Ulf Landmesser, MD, director of the Department of Cardiology, Angiology and Intensive …

Source: Medscape - Neutral

03 days 12:16:46

Featured Releases

Got News to Share? · Submit · See All

Published on May 9, 2025 - 10:00 GMT

Florida Governor Ron DeSantis Joins Olympia Pharmaceuticals in Ribbon-Cutting Ceremony for New Sister Pharmacy, Wesley ...

ORLANDO, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- Wesley Pharmaceuticals, a state-of-the-art 503B compounding facility and Olympia Pharmaceuticals' new sister brand, proudly celebrated its grand opening with a ribbon-cutting ceremony and facility tour at …

Distribution channels:
Published on May 9, 2025 - 10:29 GMT

GLP-1 Receptor Agonist Market Projected To Witness Substantial Growth, 2025-2032: Sanofi, Novo Nordisk A/S, AstraZeneca

BURLINGAME, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The GLP-1 receptor agonist market would be worth USD 28.19 billion in 2025 and grow at a compound annual growth rate (CAGR) of 12.3% to reach USD 63.54 billion by 2032. The …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 9, 2025 - 10:03 GMT

Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032: Biocon, Novo Nordisk, Gan & Lee Pharmaceuticals

BURLINGAME, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Global type 1 diabetes market is estimated to be valued at USD 16.97 Bn in 2025 and is expected to reach USD 26.22 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on May 9, 2025 - 10:35 GMT

U.S. 503B Compounding Pharmacies Market Projected To Witness Massive Growth, 2025-2032 | Athenex, Inc., Avella Specialty

BURLINGAME, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The latest report (2025-2032) on the U.S. 503B Compounding Pharmacies Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 9, 2025 - 13:03 GMT

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the ...

SAN DIEGO and TAIPEI, Taiwan, May 09, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Lotus Pharmaceutical Co., Ltd. (“Lotus”, TWSW Stock Code: 1795) today announced an exclusive license and commercialization agreement for Lotus to …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 12:30 GMT

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit secures a composition of matter patent from the Korean Intellectual Property Office for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and strategic partnerships. …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
Published on May 9, 2025 - 12:00 GMT

PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors Interim analysis from Phase 2 PYNNACLE trial expected mid-2025; PMV plans to …

Distribution channels:
Published on May 9, 2025 - 09:00 GMT

BioFlex Partners with K Pharmaceuticals to Offer Complimentary Dry Mouth Relief to Members

PHOENIX, AZ, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- BioFlex, a leader in innovative healthcare benefit solutions, is pleased to announce a new partnership with K Pharmaceuticals. K Pharmaceuticals is the proud owner of Aquoral, a prescription- …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 811,112,239 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 9, 2025 - 15:39 GMT

PowerDMARC Signs Onetic Africa as a Value-Added Distributor in Africa at GISEC 2025

DUBAI, UNITED ARAB EMIRATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- PowerDMARC, a global leader in email and domain security solutions, announced its strategic partnership with Onetic Africa as a Value-Added Distributor at GISEC Global 2025, held in …

Distribution channels: Banking, Finance & Investment Industry, Education ...
Published on May 9, 2025 - 15:37 GMT

Expert Panel Endorses NIRS Imaging to Improve Wound Documentation and Outcomes

Wound care experts highlight NIRS imaging as a vital tool to enhance documentation, guide treatment, and improve outcomes in a new Journal of Wound Care report. CALGARY, ALBERTA, CANADA, May 9, 2025 /⁨EINPresswire.com⁩/ -- Kent Imaging, a leading …

Distribution channels: Business & Economy, Companies ...
Published on May 9, 2025 - 15:32 GMT

Erythromelalgia Treatment Market Forecasted to Reach USD 3.68 Billion by 2032, CAGR of 5.5%

Erythromelalgia Treatment Market Research Report Information By Type, By Application, By Route of Administration, By Distribution Channel, and By Geography FL, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Erythromelalgia Treatment Market Overview …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 15:31 GMT

Contract Clinical Research Organization Market Expected to Surpass USD 165.56 Billion by 2032, CAGR of 9.5%

Contract Clinical Research Organization Market Research Report Information By Service Type, By Therapeutic Area, By End User, and By Geography KS, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Contract Clinical Research Organization Market …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 15:31 GMT

Wellness Apps Market Set to Hit USD 33.78 Billion by 2032 with 14.9% CAGR Growth

Wellness Apps Market Research Report Information By Type, By Platform, By Device, By Subscription Model, By Age Group, and By Geography GA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Wellness Apps Market Overview The Global Wellness …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 15:08 GMT

Green Relief Health Expands Telehealth Access to 300+ New Locations

BALTIMORE, MD, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Green Relief Health, a leading medical spa founded by Dr. Lauren Nawrocki, DNP, has announced a significant expansion of its telehealth services, now reaching more than 300 locations …

Distribution channels: Beauty & Hair Care, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 15:05 GMT

Ultimate Health Solutions Unveils Groundbreaking Wellness Innovations

Revolutionary Ultimate Grounding Mat and Ultimate Yogurt Strainer Redefine At-Home Health and Wellness CLEARWATER, FL, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Ultimate Health Solutions, a trailblazer in the health and wellness industry, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 15:00 GMT

Physicians for MA Beneficiaries Express Concerns Regarding CMS MA Rate Announcement

Coalition comment letters urge changes to V28 risk adjustment initiative ANNAPOLIS, MD, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Physicians for Medicare Advantage (MA) Beneficiaries (the Coalition), a non-profit organization of physician groups …

Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
Published on May 9, 2025 - 14:55 GMT

Nanopharmaceutics Announces NanoDOX® Hydrogel will be Tested in The University of Western Australia Clinical Trial

Nanopharmaceutics Announces NanoDOX® Hydrogel will be Tested in Patients with Genital Mycoplasmas in The University of Western Australia Phase II Clinical Trial TRON Group Inc (OTCMKTS:TGRP) ALACHUA, FL, UNITED STATES, May 9, 2025 /⁨EINPresswire.com …

Distribution channels: Chemical Industry, Companies ...
Published on May 9, 2025 - 14:41 GMT

2025 Sunglasses Trends Merge Vision Health with Modern Style - Insight From The Eye Institute

Trends in prescription sunglasses not only reflect personal style but also ocular health. Make informed decisions when selecting protective and stylish eyewear. RALEIGH, NC, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- As summer 2025 …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on May 9, 2025 - 14:39 GMT

Early Toxicity Testing Market Poised for Strong Growth with Demand for Safer, Personalized Therapies

The Business Research Company's Early Toxicity Testing Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 14:18 GMT

Autologous Cell Therapy Market to Reach USD 22.30 Billion by 2032, Growing at a CAGR of 22.1%

Autologous Cell Therapy Market Research Report Information By Product Type, By Application, By Technology, By End User, and By Geography CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Autologous Cell Therapy Market Overview The Global …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on May 9, 2025 - 14:04 GMT

Disposable Contact Lenses Market Outlook – Size, Trends, Drivers, and Forecast to 2034

Disposable Contact Lenses Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest Report Explores Market …

Distribution channels: Business & Economy, Companies ...
Published on May 9, 2025 - 13:39 GMT

Addressing the Rise of Mold Biotoxin Illnesses Amid Extreme Weather: A Metabolic Approach to Healing

WALL TOWNSHIP, NJ, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Chronic Inflammatory Response Syndrome (CIRS), a debilitating condition often triggered by mold exposure, affects millions of Americans—many of whom remain undiagnosed. With …

Distribution channels: Environment, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 13:33 GMT

Exanthema Market Size Set To Reach $2.71 Billion By 2029, At A CAGR Of 4.4%

The Business Research Company's Exanthema Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest Report …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 13:32 GMT

Essential Thrombocythemia (ET) Market Key Trend: Advancement in Personalized Medicine

The Business Research Company's Essential Thrombocythemia (ET) Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /⁨EINPresswire.com⁩/ -- The Business Research …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 13:31 GMT

Fatty Acid Oxidation Disorders (Faods) Market Set To Grow To $13.99 Billion In 2029

The Business Research Company's Fatty Acid Oxidation Disorders (FAODs) Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /⁨EINPresswire.com⁩/ -- The Business …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 13:30 GMT

Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market: Insights and Forecast Through 2034

The Business Research Company's Fibrodysplasia Ossificans Progressiva (FOP) Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /⁨EINPresswire.com⁩/ -- How Big …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 13:30 GMT

Cryptococcosis Market Forecast 2025–2034: Emerging Treatments & Market Expansion

The Business Research Company’s Cryptococcosis Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /⁨EINPresswire.com⁩/ -- How Big Is the Cryptococcosis Market and How Fast Is …

Distribution channels: Business & Economy, Emergency Services ...
Published on May 9, 2025 - 13:30 GMT

Global Dermatomycoses Market Analysis and Forecast Through 2034: Market Size, Trends And Key Segments

The Business Research Company's Global Dermatomycoses Market Analysis and Forecast Through 2034: Market Size, Trends And Key Segments LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Emergency Services ...